India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India-focused Independent Equity Research Analyst

Experienced (7 years +) in Sector-Specific Deep Dives and Comprehensive Company Research.

With a sharp focus on the Indian market, I specialize in providing in-depth analysis and insights to investors. Whether it's dissecting various sectors to identify emerging trends or conducting thorough fundamental research on individual companies, I'm dedicated to uncovering valuable opportunities and delivering actionable intelligence.

Passionate about navigating the nuances of the Indian equity landscape, I thrive on deciphering complex market dynamics and distilling them into clear, concise insights. 

While covering a sector or company-specific research, I cover the following :
1. Brief about company/sector
2.  Overall Industry landscape - History, Present and Future trends
3. Thesis and Anti-Thesis
4. Valuations
5. Financial & Forensic Analysis
6. Management Review
7. Key Monitorable Events
8. Guidance and Future Way Ahead

India Equity Analyst - Fundamental & Thematic

MAS Financial Services: From 18 Years of Stability to a INR 1 Lakh Crore Vision

Laurus Labs: 3 Core Catalyst Behind The Growth Runway

Infosys Ltd - Infosys’ AI-First Strategy: Driving Growth and Market Leadership

Business Breakdown: Laurus Labs- Breaking ARV Dependence with High-Margin Businesses?

Thematic Report on H-1B Visa Impact: Can Brain Drain in US Become Brain Gain for India?

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>Laurus Labs, an integrated pharma player focused on CDMO and generics, posted 9M FY26 revenue of INR 5,001 crore, up 30%, with EBITDA margin at 26.1%.</li>
<li>Higher margins show better product mix and stronger operating leverage. Growing CDMO scale and investments in new technologies reduce dependence on ARV business and make earnings more stable.</li>
<li>Laurus is moving from a recovery phase to a stronger growth platform, with improving profitability, focused capex, and better visibility for FY26.</li>
</ul>


Laurus Labs, an integrated pharma player focused on CDMO and generics, posted 9M FY26 revenue of INR 5,001 crore, up 30%, with EBITDA margin at 26.1%.
Higher margins show better product mix and stronger operating leverage. Growing CDMO scale and investments in new technologies reduce dependence on ARV business and make earnings more stable.
Laurus is moving from a recovery phase to a stronger growth platform, with improving profitability, focused capex, and better visibility for FY26.


Laurus Labs: Shifting from ARV Concentration to Diversified CDMO Platform